EMEA-000533-PIP01-08-M08

Key facts

Invented name
Viread
Active substance
tenofovir disoproxil fumarate
Therapeutic area
Infectious diseases
Decision number
P/0121/2020
PIP number
EMEA-000533-PIP01-08-M08
Pharmaceutical form(s)
  • Film-coated tablet
  • Granules
Condition(s) / indication(s)
  • Treatment of chronic viral hepatitis B
  • Treatment of human immunodeficiency virus (HIV-1) disease resulting in other conditions
Route(s) of administration
Oral use
Contact for public enquiries
Gilead Sciences International Limited
Tel. +44 (0)1223 897300
E-mail: regulatory.pip@gilead.com
 
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating